Prime Medicine, Inc. EPS (Diluted)

EPS (Diluted) of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Diluted) growth rates and interactive chart. Diluted earnings per share (EPS) tells investors how much of a firm's net income was allotted to each share of common stock. It is reported in a company's income statement and is especially informative for businesses with only common stock in their capital structures. Calculated as net income to common divided by the weighted average number of diluted shares outstanding (takes into account potential dilution from options or share issuance).

Highlights and Quick Summary

  • EPS (Diluted) for the quarter ending September 30, 2023 was -0.55 (a 17.02% increase compared to previous quarter)
  • Year-over-year quarterly EPS (Diluted) increased by 30.95%
  • Annual EPS (Diluted) for 2022 was -1.46 (a -23.96% decrease from previous year)
  • Annual EPS (Diluted) for 2021 was -1.92 (a 3740.0% increase from previous year)
  • Annual EPS (Diluted) for 2020 was -0.05 (a 66.67% increase from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Diluted) of Prime Medicine, Inc.

Most recent EPS (Diluted)of PRME including historical data for past 10 years.

Interactive Chart of EPS (Diluted) of Prime Medicine, Inc.

Prime Medicine, Inc. EPS (Diluted) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -0.55 -0.47 -0.44
2022 -0.42 -0.37 -1.46
2021 -1.92
2020 -0.05
2019 -0.03

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology